AXA Inventory: Updating The Thesis On This French Insurance coverage


Pricey readers,

On this article, we’ll have a look at AXA (OTCQX:AXAHF) as soon as once more. This firm has, like most financials, been beneath a good quantity of share worth and valuation strain. Whereas this in fact means we may have invested at a larger upside, that kind of clairvoyance does not actually exist, and we have to take care of the state of affairs now we have right now.

And the state of affairs now we have right now is an undervalued monetary with nice fundamentals and a good quantity of upside.

AXA – Let’s revisit French financials

AXA is, as I wrote in my authentic piece on the corporate, an important enterprise within the monetary sector. The corporate’s 200+ yr historical past ensures secure fundamentals, a minimum of in concept. The corporate is an absolute market chief within the insurance coverage market and is among the many prime/largest insurance coverage corporations on earth. It’s, on the similar time, additionally one of many world’s largest asset managers, working beneath the AXA IM in Europe, and beneath AllianceBernstein (AB) within the USA.

Yield and upside are the battle cry for buyers in AXA akin to myself. The present valuation provides an interesting yield of over 7% and that from one of many largest insurance coverage companies on the planet. The corporate’s dividend coverage requires a comparatively constant portion of earnings, with out a lot flexibility to determine a dividend custom or proceed one throughout poor years, as seen in 2019 when the corporate lower the dividend.

Whereas buyers in AXA should settle for comparatively excessive quantities of potential volatility – as indicated by the corporate’s historical past – this volatility remains to be offset by a excessive diploma of basic security. AXA has no worrying debt and is A rated or equal by each one of many main businesses on the market, and has a 2021 solvency II ratio of 217%.

AXA is, to place it merely, a multi-line insurer with a long time of expertise within the trade.

AXA Revenue


Its begin as a tiny French operation and its present standing as a world chief is a testomony to administration expertise over the previous 40-50 years. The corporate has a historic tendency of specializing in high-growth markets to steadiness out their mature market incomes (which are typically decrease, however extra secure). On the similar time, the corporate just isn’t tied to anyone funding and is fast to chop an unprofitable operation from its portfolio when wanted. The French big has additionally acquired companies in Colombia, Nigeria, Egypt, Azerbaijan, and Poland, one of the engaging insurance coverage markets in Central and Jap Europe.

AXA earnings and dividends


On this, AXA shares tendencies with different French corporations, the place the enterprise has publicity to what had been beforehand French colonies in Africa. These tendencies are additionally discovered within the telecommunications sector, banking, and different areas. France has a number of publicity to, and market curiosity for components of the African market. I view this as a future benefit.

AXA remains to be, as of penning this piece, within the midst of a strategic transformation that’s going in the direction of its conclusion, which alongside its opponents is a extra fee-based mannequin construction. The corporate’s earnings are actually 90%+ fee-based, which is in fact a bonus shifting into the present atmosphere.

The corporate’s operations as of 2021 are reported by way of Property & Informal Insurance coverage, Life & Financial savings, Well being Insurance coverage, and Asset administration. There’s additionally a “Holdings & Different phase). Over the previous few years, the corporate has slowly shifted away from a life focus because of the rate of interest sensitivity that overexposure to the phase brings. In the present day, barely north of half of the corporate’s earnings, and fewer than half of the revenues come from the Life phase, with the rest coming from Non-life and asset administration.

AXA non-life and asset management


Since the entire firm’s segments confirmed important development for 2021 (151% for P&C), this firm began out in 2022 with a superb base market place. RoE noticed important enhancements and is now on the high-end of the corporate’s goal vary, shut to fifteen%, and the Solvency II ratio elevated by nearly 17% YoY. The corporate’s gearing is, as of 2021, lower than 27%, with one cost of a Tier 1 debt of $850M in early 2022, and issuance of latest debt in early 2022 as effectively, at what’s now thought of a superb value.

I wrote earlier that it is truthful to think about AXA a French response to the biggest insurance coverage firm on the earth, Allianz (OTCPK:ALIZY). I nonetheless view such a comparability as legitimate and making AXA an fascinating funding.

The corporate’s re-aligning of its portfolio is paying off, with a decrease reliance on capital-intensive Financial savings merchandise and interest-rate-sensitive Life insurance coverage operations. Gross sales in these legacy segments stay strong, and the corporate has key market management in France right here at near 9% of the complete market, in addition to 10% of the Swiss and nearly 8% of the Belgian market. It lacks the German market focus that Allianz has – however we do not want it. We now have Allianz for that.

AXA earnings target


By investing in AXA we get interesting publicity to sturdy European markets that we do not get as a lot with Allianz.

The tendencies in Medical insurance are what drives the corporate’s segments on this space. We’re seeing a shift from particular person protection/insurance policies to group insurance policies because of the introduction of obligatory company well being protection, even when that is considerably nonetheless depending on how particular person nations as the event is not 1-1 in every single place.

By the XL M&A, AXA is now the world’s main P&C Industrial traces insurer and is integral to the corporate’s shift from life to broader portfolio composition.

Whereas the asset administration enterprise appears small, it really generates over €2B in revenues and has over €804B in AUM. AXA is, due to this, among the many 20 largest asset managers in the complete world. This department of AXA is in want of development and scale, and Allianz is considerably forward of AXA on this.

The corporate additionally outperforms on different ranges, akin to producing important capital above steerage for 2021, and with over €4.4B in money in holding, getting ready it effectively for the cataclysm that has been the 1H22 in Europe as a result of a mixture of macro and different tendencies.

The very fact is that AXA has dropped 21.7% since my final article, underperforming most indices. My place remains to be inexperienced as a result of I purchased my AXA at dirt-cheap valuations inclusive of dividends and FX. Nonetheless, I consider the market is now severely mispricing AXA and its future potential.

That is the ability of valuation-centric dividend investing. Now, my place was initially about €7,000 – and up about 95% together with dividends and FX. When AXA right now, we’re seeing a really resilient firm regardless of probably unfavorable financial tendencies within the close to future. The dividend yield can also be providing an upside potential, due to a better dividend and given the brand new payout vary at 50-60% of adjusted earnings. With XL included, we should always see continued development in that dividend for the following few years or so.

(Looking for Alpha, AXA article)

As a result of as the corporate’s personal forecasts counsel, this isn’t a downtrend valuation based mostly on poor earnings going ahead, however one opposite to the anticipated development.

AXA expects earnings development for 2022E, and analysts agree. S&P International forecasts a 2% 2022E EPS development, and FactSet is at 1.8%, calling for the ADR to generate $3.11 EPS for the fiscal.

Let’s take a look at what precisely this may imply for the valuation.

AXA’s valuation

If we’re to consider the market’s evaluation of AXA, then the market believes the corporate to be price not more than 6.94X P/E, for a 7%-yielding insurance coverage enterprise with an A grade credit standing. A bit steep when you ask me, particularly for the reason that firm usually trades a minimum of 3X P/E above that.

2023-2024E should not anticipated to be paltry years both, with EPS development of 5-7% on the excessive finish, which might counsel a major undervaluation at this explicit juncture.

AXA valuation

AXA valuation (F.A.S.T graphs)

The corporate usually does not keep at these types of valuation ranges for very lengthy. Whereas it is fully doable for us to go deeper “down south” right here, I do not see the elemental threat to this when you’re investing long-term. As a long-term funding, this firm has a major upside. Even to only a 10X P/E, that upside is 28% yearly, or near 80% complete RoR to 2024E targets. That is alpha, as I see it.

Even when the corporate had been to commerce flat round that 6-8X P/E, the upside is 10-15% yearly or 30-40%, and that is in flat buying and selling for the following few years.

Primarily based on this valuation, there are only a few eventualities that I see the place the corporate would end in a long-term unfavourable RoR. On a peer foundation, AXA’s closest friends are Allianz (OTCPK:ALIZF), Zurich (OTCQX:ZURVY), Generali (OTCPK:ARZGY), and Sampo (SAXPY). On this group, the common P/E lies near 11-12X – AXA is undervalued to this a number of – and can also be undervalued to P/B multiples, and provides a larger yield than all of its opponents at present valuations. From a peer-based perspective, the corporate is now at a deep low cost to averages, with the very best low cost in P/B.

The common at the moment is round €30.5/share, and 19 out of 20 analysts take into account the corporate both a “BUY” or an “Outperform”. This goal has not shifted for over 5 months – not on common. Whereas I’d say the €30.5 worth is justifiable –I’d go decrease to a €28.5/share worth goal, extra according to a fair-value peer common.

However even on such a goal foundation, the present undervaluation we see in AXA may be very important. I’d say it is near 40% right here, and AXA needs to be thought of one of many major buys when you’re a conservative dividend investor.


My thesis for AXA is as follows:

  • This is among the largest asset managers and insurers in all of Europe and the world. It has rock-solid foundations and a 200-year historical past. Beneath the appropriate circumstances and on the proper valuation, this firm is a particular “BUY”.
  • I consider {that a} conservative estimate of the corporate’s talents requires a minimum of a goal of €28.5/share, which might suggest a 35%+ upside for the corporate based mostly on the place I commerce right now.
  • Primarily based on this, I’d take into account AXA a “BUY” right here.

Keep in mind, I am all about:

  1. Shopping for undervalued – even when that undervaluation is slight, and never mind-numbingly huge – corporations at a reduction, permitting them to normalize over time and harvesting capital positive factors and dividends within the meantime.
  2. If the corporate goes effectively past normalization and goes into overvaluation, I harvest positive factors and rotate my place into different undervalued shares, repeating #1.
  3. If the corporate does not go into overvaluation, however hovers inside a good worth, or goes again right down to undervaluation, I purchase extra as time permits.
  4. I reinvest proceeds from dividends, financial savings from work, or different money inflows as laid out in #1.

AXA is at the moment a “BUY”.

Previous post Candy Residence Finance Director strikes submit to Lebanon
Next post New Advantages and Welcome Bonus